KNSA logo

KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

2,486
Mkt Cap
$3.79B
Volume
254,229.00
52W High
$50.03
52W Low
$18.26
PE Ratio
66.47
KNSA Fundamentals
Price
$49.08
Prev Close
$49.55
Open
$49.60
50D MA
$45.49
Beta
0.74
Avg. Volume
675,062.87
EPS (Annual)
$0.7471
P/B
6.66
Rev/Employee
$1.85M
$2,853.31
Loading...
Loading...
News
all
press releases
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month High - Still a Buy?
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 1-Year High - Should You Buy...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Aberdeen Group plc Buys 241,876 Shares of Kiniksa Pharmaceuticals International, plc $KNSA
Aberdeen Group plc grew its stake in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 152.4% in the 4th quarter, according to its most recent disclosure with the...
MarketBeat·13h ago
News Placeholder
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine ratings firms that are presently covering...
MarketBeat·5d ago
News Placeholder
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 1-Year High - Should You Buy?
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 52-Week High - Time to Buy...
MarketBeat·6d ago
News Placeholder
Hennion & Walsh Asset Management Inc. Trims Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA
Hennion & Walsh Asset Management Inc. lessened its holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 35.0% during the 4th quarter, according to its most recent...
MarketBeat·6d ago
News Placeholder
JPMorgan Chase & Co. Has $7.47 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA
JPMorgan Chase & Co. boosted its stake in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 42.3% during the 3rd quarter, according to the company in its most recent filing...
MarketBeat·7d ago
News Placeholder
SG Americas Securities LLC Has $22.33 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA
SG Americas Securities LLC lifted its holdings in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 288.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 541,396 shares of the company's stock after purchasing an additio...
MarketBeat·11d ago
News Placeholder
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by Braidwell LP
Braidwell LP reduced its stake in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 41.7% in the 3rd quarter, according to the company in its most recent disclosure...
MarketBeat·23d ago
News Placeholder
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by ArrowMark Colorado Holdings LLC
ArrowMark Colorado Holdings LLC trimmed its position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 26.9% in the 3rd quarter, according to the company in its most recent...
MarketBeat·24d ago
News Placeholder
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Cut to Hold at Wall Street Zen
Wall Street Zen downgraded Kiniksa Pharmaceuticals International from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·25d ago
<
1
2
...
>

Latest KNSA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.